Moberg's BUPIZENGE™ - Sage Group Offers An Opportunity for Leadership in Pain Relief for Oral Mu
Stockholm, Sweden, 8 September 2018 – Moberg has appointed The Sage Group to lead the BUPIZENGE™ partnering program. Moberg Pharma is a rapidly growing, publicly-traded, Swedish pharmaceutical company that commercializes proprietary and acquired products in the global market. Initially, the company specialized in innovative topical treatments in niche indications but is now focusing on skin and nails conditions Moberg markets OTC brands in the U.S. and sell through distributo